Tonix Pharmaceuticals Holding (TNXP) Earnings Date & Reports

Industry: @Pharmaceuticals Other

A.I. Advisor

published Earnings

TNXP is expected to report earnings to fall 83.87% to -310 cents per share on November 04

Tonix Pharmaceuticals Holding TNXP Stock Earnings Reports

Q3'24

Est.

$-3.11

Q2'24

Missed

by $14.05

Q1'24

Beat

by $3.04

Q4'23

Est.

$-6.85

Q2'23

Beat

by $0.08

The last earnings report on August 19 showed earnings per share of -1928 cents, missing the estimate of -523 cents. With 207.62M shares outstanding, the current market capitalization sits at 20.44M.

View a ticker or compare two or three

Compare

TNXP

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For TNXP
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company which engages in developing and manufacturing pharmaceuticals

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

26 Main Street

Phone

+1 862 799-8599

Employees

103

Web

https://www.tonixpharma.com